The Evolving Paradigm of Intracoronary Tirofiban Administration in STEMI

Heart Lung Circ. 2024 Nov;33(11):1503-1506. doi: 10.1016/j.hlc.2024.10.004.

Authors

Mohammad Sarraf¹, Vinayak Nagaraja²

Affiliations

¹ Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.
² Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address: nagaraja.vinayak@mayo.edu.

PMID: 39521575
DOI: 10.1016/j.hlc.2024.10.004

No abstract available

Keywords: Antithrombotic therapy; MACE; Major adverse cardiovascular events; ST-elevation myocardial infarction; STEMI.

Publication types

Editorial